ArticleEuropean urology open science2022

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data.

Sebastiaan Remmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.